What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Virus
Stanislas Pol mostly deals with Internal medicine, Hepatitis C virus, Gastroenterology, Immunology and Hepatitis C.
His research in Internal medicine intersects with topics in Ribavirin, Surgery and Viral load.
In his study, Transplantation is strongly linked to Liver disease, which falls under the umbrella field of Hepatitis C virus.
His Gastroenterology study integrates concerns from other disciplines, such as Pibrentasvir, Glecaprevir, Fibrosis, Pathology and Telaprevir.
In his research on the topic of Immunology, Immunotherapy is strongly related with Virology.
As part of the same scientific family, Stanislas Pol usually focuses on Hepatitis C, concentrating on Sofosbuvir and intersecting with Ledipasvir.
His most cited work include:
- Telaprevir for retreatment of HCV infection. (1384 citations)
- Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. (928 citations)
- Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. (730 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Gastroenterology, Immunology, Hepatitis C virus and Virology.
His studies in Internal medicine integrate themes in fields like Chronic hepatitis, Ribavirin and Surgery.
His Ribavirin research incorporates elements of Regimen and Interferon.
His research integrates issues of Fibrosis, Adverse effect, Daclatasvir and Viral load in his study of Gastroenterology.
Stanislas Pol interconnects Liver biopsy and Alpha interferon in the investigation of issues within Hepatitis C virus.
His work deals with themes such as Liver disease, Hepatocellular carcinoma, Transplantation and Cohort, which intersect with Cirrhosis.
He most often published in these fields:
- Internal medicine (51.89%)
- Gastroenterology (37.81%)
- Immunology (29.47%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (51.89%)
- Gastroenterology (37.81%)
- Cirrhosis (18.90%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Gastroenterology, Cirrhosis, Hepatitis C and Hepatitis C virus.
His Internal medicine study incorporates themes from Ribavirin and Sofosbuvir.
His studies deal with areas such as Hepatitis B, Chronic hepatitis, Coinfection, Prospective cohort study and Hepatitis B virus as well as Gastroenterology.
His studies examine the connections between Cirrhosis and genetics, as well as such issues in Liver disease, with regards to Alcoholic liver disease and Retrospective cohort study.
His Hepatitis C research is multidisciplinary, relying on both Randomized controlled trial, Surgery, Hepatology, Kidney disease and Adverse effect.
Research on Virology and Immunology is a part of his Hepatitis C virus study.
Between 2016 and 2021, his most popular works were:
- Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications (258 citations)
- Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment. (239 citations)
- Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection (217 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Virus
Internal medicine, Gastroenterology, Cirrhosis, Hepatitis C and Hepatitis C virus are his primary areas of study.
He combines topics linked to Pibrentasvir with his work on Internal medicine.
His Gastroenterology research is multidisciplinary, incorporating elements of Ribavirin, Sofosbuvir, Glecaprevir, Prospective cohort study and Hepatitis B virus.
Stanislas Pol has included themes like Interferon alfa and Adverse effect in his Ribavirin study.
Stanislas Pol usually deals with Hepatitis C and limits it to topics linked to Randomized controlled trial and Placebo.
Within one scientific family, he focuses on topics pertaining to Diabetes mellitus under Hepatitis C virus, and may sometimes address concerns connected to Kidney transplantation, Transplantation and Clinical endpoint.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
